LIVN ▼ -0.6% - LivaNova PLC $LIVN Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova’s VNS Therapy for Drug-Resistant Epilepsy 23-OCT-2026 09:01 AM ET